Background: We asked whether the integration of digital behavioral counseling with employer-sponsored annual biometric screening could reduce the risk of obesity-related chronic disease in a U.S. workforce.

Methods: We evaluated a cohort (n=113) who participated in an employer-sponsored annual wellness program with year-end biometric screening and enrolled in a digital behavioral counseling program. Individuals were included in the analysis if they participated in the wellness program in 2015, had prediabetes (fasting glucose (FG) 100 to 125mg/dL or Hb1Ac 5.7 to 6.4%) and a BMI ≥25 kg/m2 in 2016, and agreed to participate in a digital behavioral counseling program followed by year-end biometric screening in 2017.

Results: The participants were 75% women and 61% Caucasian, 28% African American. At the 2016 year-end biometric screening, which preceded digital behavioral counseling, the characteristics of the cohort (mean± sd) were age, 50.0±9.9 years; BMI, 37.1±8.6 kg/m2; Hb1Ac, 6.1±0.6%; and FG, 106.9±24.2 mg/dL. Following behavioral counseling, 28% of the participants lost 5% or more of body weight. Hb1Ac and FG levels both fell below prediabetic thresholds for 32% of the participants. Other biometric outcome measures improved (Table).

Conclusions: Digital behavioral counseling was effective in reducing risk for both diabetes and cardiovascular disease in a workforce cohort.

    
 Change in annual biometric screening results  
 The year preceding counseling (2015 to 2016) The year counseling received (2016 to 2017) P value (paired t-Test) 
BMI (kg/m2+0.66 -1.18 <0.0001 
Hb1Ac (%) +0.06 -0.22 0.001 
Fasting Glucose (mg/dL) +5.85 -2.84 0.02 
Triglycerides (mg/dL) +12.0 -17.2 0.01 
10-year ASCVD risk* (%) +1.83 -0.48 0.01 
    
 Change in annual biometric screening results  
 The year preceding counseling (2015 to 2016) The year counseling received (2016 to 2017) P value (paired t-Test) 
BMI (kg/m2+0.66 -1.18 <0.0001 
Hb1Ac (%) +0.06 -0.22 0.001 
Fasting Glucose (mg/dL) +5.85 -2.84 0.02 
Triglycerides (mg/dL) +12.0 -17.2 0.01 
10-year ASCVD risk* (%) +1.83 -0.48 0.01 

*Atherosclerotic Cardiovascular Disease risk (2013 ACC/AHA Cardiovascular Risk Guideline)

Disclosure

C.E. Birse: Employee; Self; Quest Diagnostics. Stock/Shareholder; Self; Quest Diagnostics. R.J. Lagier: Employee; Self; Quest Diagnostics. P. Chew: Employee; Self; Omada Health, Inc. C.B. Jasik: Employee; Self; Omada Health, Inc. E.N. Madero: Employee; Self; Omada Health, Inc..

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.